福瑞医科 reported revenue of ¥0.75B for the period ended 2026-06-30, +5.8% year on year. Net income was ¥0.11B, a 15.2% net margin on a 75.8% gross margin. The largest revenue line is 设备及技术 at 69% of the total. Free cash flow for the period was ¥0.05B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.75B | +5.8% |
| Gross profit | ¥0.57B | — |
| Operating income | ¥0.17B | — |
| Net income | ¥0.11B | +46.9% |
| Gross margin | 75.8% | Net margin 15.2% |
| Revenue Q/Q | +9.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 设备及技术 | ¥0.52B | 69.1% |
| 药品 | ¥0.19B | 25.0% |
| 医疗服务及其他 | ¥0.04B | 5.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.18B | 24.2% |
| R&D | ¥0.07B | 8.7% |
| SG&A | ¥0.34B | 45.1% |
| Tax & other | ¥0.05B | 7.2% |
| Item | Amount |
|---|---|
| Total assets | ¥3.47B |
| Total liabilities | ¥0.98B |
| Shareholders' equity | ¥2.49B |
| Equity / assets | 71.7% |
| Operating cash flow | ¥0.08B |
| Capital expenditure | ¥0.03B |
| Free cash flow | ¥0.05B |
| Cash conversion (OCF / net income) | 154% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
世纪鼎利 ・ 琏升科技 ・ 中青宝 ・ 航宇微 ・ 鼎龙股份 ・ 万邦达 ・ 中创环保 ・ 万顺新材 ・ 蓝色光标 ・ 旗天科技 ・ 中能电气 ・ 天龙集团
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies